Clinical course of plasmacytoid urothelial carcinoma of the upper urinary tract: a case report

Bastian Keck; Johannes Giedl; Frank Kunath; Peter Juergen Goebell; Dirk Gerhard Engehausen; Arndt Hartmann; Bernd Wullich

doi:10.1159/000335519

Clinical course of plasmacytoid urothelial carcinoma of the upper urinary tract: a case report

Urol Int. 2012;89(1):120-2. doi: 10.1159/000335519. Epub 2012 Feb 17.

Authors

Bastian Keck¹, Johannes Giedl, Frank Kunath, Peter Juergen Goebell, Dirk Gerhard Engehausen, Arndt Hartmann, Bernd Wullich

Affiliation

¹ Department of Urology, University Hospital Erlangen, Erlangen, Germany. bastian.keck @ uk-erlangen.de

PMID: 22354006
DOI: 10.1159/000335519

Abstract

Plasmacytoid urothelial carcinoma of the bladder represents a rare and aggressive variant of urothelial carcinoma, which is usually diagnosed at an advanced pathologic stage. Until now, no reports exist on this rare tumor type in the upper urinary tract. Herein, we present the first report on the clinical course of a metastatic plasmacytoid urothelial carcinoma of the renal pelvis and show its unfavorable outcome despite multimodal therapy.

Publication types

Case Reports

MeSH terms

Aged
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Biopsy
Carboplatin / administration & dosage
Carcinoma / diagnosis
Carcinoma / secondary
Carcinoma / therapy*
Chemoradiotherapy
Chemotherapy, Adjuvant
Deoxycytidine / administration & dosage
Deoxycytidine / analogs & derivatives
Fatal Outcome
Gemcitabine
Humans
Kidney Neoplasms / diagnosis
Kidney Neoplasms / pathology
Kidney Neoplasms / therapy*
Kidney Pelvis / pathology
Kidney Pelvis / surgery*
Lymph Node Excision
Lymphatic Metastasis
Male
Nephrectomy*
Treatment Failure
Urothelium / pathology
Urothelium / surgery*

Substances

Deoxycytidine
Carboplatin
Gemcitabine